Literature DB >> 20969570

Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex.

Erin R Hascup1, Kevin N Hascup, Michelle Stephens, Francois Pomerleau, Peter Huettl, Alain Gratton, Greg A Gerhardt.   

Abstract

Glutamate in the prefrontal cortex (PFC) plays a significant role in several mental illnesses, including schizophrenia, addiction and anxiety. Previous studies on PFC glutamate-mediated function have used techniques that raise questions on the neuronal versus astrocytic origin of glutamate. The present studies used enzyme-based microelectrode arrays to monitor second-by-second resting glutamate levels in the PFC of awake rats. Locally applied drugs were employed in an attempt to discriminate between the neuronal or glial components of the resting glutamate signal. Local application of tetrodotoxin (sodium channel blocker), produced a significant (∼ 40%) decline in resting glutamate levels. In addition significant reductions in extracellular glutamate were seen with locally applied ω-conotoxin (MVIIC; ∼ 50%; calcium channel blocker), and the mGluR(2/3) agonist, LY379268 (∼ 20%), and a significant increase with the mGluR(2/3) antagonist LY341495 (∼ 40%), effects all consistent with a large neuronal contribution to the resting glutamate levels. Local administration of D,L-threo-β-benzyloxyaspartate (glutamate transporter inhibitor) produced an ∼ 120% increase in extracellular glutamate levels, supporting that excitatory amino acid transporters, which are largely located on glia, modulate clearance of extracellular glutamate. Interestingly, local application of (S)-4-carboxyphenylglycine (cystine/glutamate antiporter inhibitor), produced small, non-significant bi-phasic changes in extracellular glutamate versus vehicle control. Finally, pre-administration of tetrodotoxin completely blocked the glutamate response to tail pinch stress. Taken together, these results support that PFC resting glutamate levels in rats as measured by the microelectrode array technology are at least 40-50% derived from neurons. Furthermore, these data support that the impulse flow-dependent glutamate release from a physiologically -evoked event is entirely neuronally derived.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969570      PMCID: PMC2996468          DOI: 10.1111/j.1471-4159.2010.07066.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  76 in total

1.  Glutamate-glutamine cycle and aging in striatum of the awake rat: effects of a glutamate transporter blocker.

Authors:  G Segovia; A Del Arco; L Prieto; F Mora
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Real time in vivo measures of L-glutamate in the rat central nervous system using ceramic-based multisite microelectrode arrays.

Authors:  F Pomerleau; B K Day; P Huettl; J J Burmeister; G A Gerhardt
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

3.  Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS.

Authors:  Jason J Burmeister; Francois Pomerleau; Michael Palmer; Brian K Day; Peter Huettl; Greg A Gerhardt
Journal:  J Neurosci Methods       Date:  2002-09-30       Impact factor: 2.390

4.  Vesicular and non-vesicular glutamate release in the nucleus accumbens in conditions of a forced change of behavioral strategy.

Authors:  N B Saul'skaya; M O Mikhailova
Journal:  Neurosci Behav Physiol       Date:  2005-09

5.  Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats.

Authors:  M G Giovannini; A Rakovska; R S Benton; M Pazzagli; L Bianchi; G Pepeu
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  Multiple pathways for regulation of the KCl-induced [3H]-GABA release by metabotropic glutamate receptors, in primary rat cortical cultures.

Authors:  H Schaffhauser; F Knoflach; J R Pink; Z Bleuel; J Cartmell; F Goepfert; J A Kemp; J G Richards; G Adam; V Mutel
Journal:  Brain Res       Date:  1998-01-26       Impact factor: 3.252

7.  Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.

Authors:  Annalisa Buffo; Inmaculada Rite; Pratibha Tripathi; Alexandra Lepier; Dilek Colak; Ana-Paula Horn; Tetsuji Mori; Magdalena Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

Review 8.  Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease.

Authors:  J T Greenamyre
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Urethane affects the rat visual system at subanesthetic doses.

Authors:  R S Dyer; G C Rigdon
Journal:  Physiol Behav       Date:  1987

10.  Simultaneous monitoring of the seizure-related changes in extracellular glutamate and gamma-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling.

Authors:  Y Ueda; N Tsuru
Journal:  Epilepsy Res       Date:  1995-03       Impact factor: 3.045

View more
  55 in total

1.  Hypersensitive glutamate signaling correlates with the development of late-onset behavioral morbidity in diffuse brain-injured circuitry.

Authors:  Theresa Currier Thomas; Jason M Hinzman; Greg A Gerhardt; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2011-12-01       Impact factor: 5.269

2.  The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.

Authors:  Kenichi Fukumoto; Michihiko Iijima; Shigeyuki Chaki
Journal:  Neuropsychopharmacology       Date:  2015-08-06       Impact factor: 7.853

3.  Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Greg A Gerhardt; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

4.  Glial responses to implanted electrodes in the brain.

Authors:  Joseph W Salatino; Kip A Ludwig; Takashi D Y Kozai; Erin K Purcell
Journal:  Nat Biomed Eng       Date:  2017-11-10       Impact factor: 25.671

5.  Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.

Authors:  Ashley E Lepack; Eunyoung Bang; Boyoung Lee; Jason M Dwyer; Ronald S Duman
Journal:  Neuropharmacology       Date:  2016-09-12       Impact factor: 5.250

6.  Glutaraldehyde cross-linked glutamate oxidase coated microelectrode arrays: selectivity and resting levels of glutamate in the CNS.

Authors:  Jason J Burmeister; Verda A Davis; Jorge E Quintero; Francois Pomerleau; Peter Huettl; Greg A Gerhardt
Journal:  ACS Chem Neurosci       Date:  2013-05-09       Impact factor: 4.418

Review 7.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

8.  Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AβPP/PS1 mice.

Authors:  Erin R Hascup; Sarah O Broderick; Mary K Russell; Yimin Fang; Andrzej Bartke; Heather A Boger; Kevin N Hascup
Journal:  J Neurochem       Date:  2019-01-03       Impact factor: 5.372

Review 9.  Are BDNF and glucocorticoid activities calibrated?

Authors:  F Jeanneteau; M V Chao
Journal:  Neuroscience       Date:  2012-09-26       Impact factor: 3.590

Review 10.  Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Authors:  Jason M Dwyer; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.